Procter & Gamble Maintains Fiscal 2027 Guidance Amid Organic Sales Growth
Procter & Gamble (PG) reported a strong start to fiscal 2027, with organic sales increasing by 4.0% compared to the previous year. This growth was primarily driven by a 2.4-point increase in volume, supplemented by modest gains in pricing and product mix. Despite these positive top-line results, the company is navigating a significant $1.4 billion after-tax cost headwind. Consequently, management has maintained its full-year fiscal 2027 outlook, projecting organic sales growth between 1% and 3% and core earnings per share (EPS) in the range of $6.89 to $7.11.
Tickers: $PG
Topics: organic sales growth pricing strategy volume increase
Read the full article at Seeking Alpha
Part of the story Investment Required to Fund a $3,000 Annual Vacation via Procter & Gamble Dividends (5 articles)